CKII alpha prime polypeptide Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-379B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Predicted:
Bovine (100%). Backed by our 100% Guarantee.
Applications
Immunoprecipitation, Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 350 and the C-terminus (residue 350) of human Casein Kinase 2, alpha 2 using the numbering given in entry NP_001887.1 (GeneID 1459).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for CKII alpha prime polypeptide Antibody [Biotin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CKII alpha prime polypeptide
Long Name
Casein kinase II subunit alpha'
Alternate Names
CK II alpha', CK2A2, CSNK2A2
Gene Symbol
CSNK2A2
Additional CKII alpha prime polypeptide Products
Product Documents for CKII alpha prime polypeptide Antibody [Biotin]
Product Specific Notices for CKII alpha prime polypeptide Antibody [Biotin]
[PUBLIC NOTES]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...